Prof. Banu Atalar
4
reviews
24/02/2022
11/09/2021
21/08/2020
19/07/2014
Professor Banu Atalar is a radiation oncologist with more than 25 years of experience and Director of the Radiation Oncology Department at Anadolu Medical Center (Gebze, Turkey, since 2026). She is the current President of the Turkish Society for Radiation Oncology (TROD, 2025–2027).
She graduated from Istanbul Faculty of Medicine (Istanbul University) in 1999 and completed her residency in radiation oncology at Cerrahpaşa Faculty of Medicine. In 2011, she completed a clinical research fellowship in stereotactic radiosurgery at Stanford University, Department of Radiation Oncology (mentors: John Adler, Iris Gibbs, Scott Soltys). She earned the titles of Associate Professor and Professor at Acıbadem Mehmet Ali Aydınlar University.
Areas of expertise: lung cancer, central nervous system tumors and brain metastases, prostate cancer and urological tumors, gastrointestinal tumors, breast cancer, gynecological tumors, and head and neck tumors. She places a particular focus on MR-guided adaptive radiotherapy (MRgSBRT/SMART) and stereotactic radiosurgery.
Author of more than 80 scientific publications. Member of the organizing committees of RSS and ESTRO, Chair of the ESTRO National Societies Committee (2024–2027). Recipient of the Honorary Fellow of the American College of Radiology (2025) and the IASLC International Mentorship Award (2018).
Achievements and awards
About Dr. Banu Atalar
- Stereotactic body radiotherapy (SBRT) and radiosurgery (SRS)
- MR-guided adaptive radiotherapy (MRgSBRT/SMART)
- Lung cancer and thoracic tumors
- Central nervous system tumors and brain metastases
- Urological tumors (prostate cancer)
- Gastrointestinal tumors
- Breast cancer
- Gynecological tumors
- Head and neck tumors
- 1993–1999 — Istanbul Faculty of Medicine, Istanbul University, MD degree
- 2000–2005 — residency in radiation oncology, Cerrahpaşa Faculty of Medicine, Istanbul
- 2011 — clinical research fellowship in stereotactic radiosurgery, Stanford University, Department of Radiation Oncology (mentors: John Adler, Iris Gibbs, Scott Soltys)
- Associate Professor — Acıbadem Mehmet Ali Aydınlar University
- Professor — Acıbadem Mehmet Ali Aydınlar University
- Cerrahpaşa Faculty of Medicine, Department of Radiation Oncology
- Italian Hospital (VKV), Istanbul
- Acıbadem Maslak Hospital, Istanbul
- 2026 – present — Director of the Radiation Oncology Department, Anadolu Medical Center, Gebze
Author of more than 80 scientific publications in leading international journals on radiotherapy, stereotactic radiosurgery, MR-guided radiotherapy, and radiation oncology of rare tumors.
- Chair of the ESTRO National Societies Committee (2024–2027)
- Member of the RSS Scientific Meetings Organizing Committee (2023–2025)
- Member of the RSS Nominating Committee (2024)
- Chair of the TROD Young Committee (2021–2023)
- Organizer of the TROD National Congress (2023)
- Member of the ASCO Guidelines Committee (2013–2018)
- Co-author of works on MRgSBRT for lung, liver, prostate, and CNS tumors
- Turkish Society for Radiation Oncology (TROD), President
- European Society for Radiotherapy and Oncology (ESTRO)
- American Society of Clinical Oncology (ASCO)
- Radiosurgery Society (RSS)
- American Society for Radiation Oncology (ASTRO)
- American College of Radiology (ACR), Honorary Fellow
Anadolu Medical Center is a private multidisciplinary medical center in Gebze (Kocaeli province, Turkey), founded in 2005. It is a strategic affiliate of Johns Hopkins Medicine (USA), which ensures the exchange of expertise, treatment protocols, and joint specialist training.
The clinic is accredited by the Joint Commission International (JCI) and is repeatedly ranked among the leading oncology centers in Europe. The Radiation Oncology Department is equipped with state-of-the-art radiotherapy systems, including MR-Linac (MRIdian), stereotactic radiosurgery (CyberKnife, Linac-based SRS), IMRT/VMAT, and brachytherapy.
Patients receive multidisciplinary cancer treatment involving radiation oncologists, surgical oncologists, medical oncologists, and medical physicists.
